Form D · Private Equity Fund
Abingworth Clinical Co-Development 3 Feeder, L.P.
Washington, DC · CIK 0002070906
Offering snapshot reported Jun 25, 2025 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-549753
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| TCG Capital Markets L.L.C. | 291767 | TCG Capital Markets L.L.C. · CRD 291767 |
| Asante Capital Group Advisors, LLC | 155178 | Asante Capital Group Advisors, LLC · CRD 155178 |
Source: Form D, filed Jun 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Accd 3 Gp Lp | Promoter |
| N/A Accd 3 Holdings, L.L.C. | Promoter |
| Jeremy Anderson | Executive |
| Christina Gibbs | Executive |
| David Lobe | Executive |
| Robert Rosen | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1001 Pennsylvania Ave., N.W. Suite 220 South
Washington, DC, 20004
Washington, DC, 20004